{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:06:55Z","timestamp":1793506015773,"version":"4.5.0"},"reference-count":74,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T00:00:00Z","timestamp":1750377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging"],"abstract":"<jats:p>Rapamycin, an antibiotic discovered in the 1970s from <jats:italic>Streptomyces hygroscopicus<\/jats:italic> on Easter Island (Rapanui), has become a critical tool in biomedical research. Initially recognized for its potent antifungal and immunosuppressive properties, rapamycin has recently gained significant attention for anti-aging therapy and seizure treatment via mTOR pathway inhibition. The mechanistic target of the rapamycin (mTOR) pathway is an evolutionarily conserved metabolic signaling cascade that regulates cell division, growth, and survival. There is growing evidence that mTOR pathway activity accelerates aging and the development of age-related diseases including cancer, atherosclerosis, diabetes, and declining immune function. Therefore physicians and \u201cbiohackers\u201d are using mTOR inhibition via rapamycin (and rapamycin analogs) off-label for prevention of age-related conditions despite not being widely recognized as a treatment by the broader clinical community. Currently, rapamycin (i.e., sirolimus and everolimus) is FDA approved for the prevention of transplant organ rejection and for anti-seizure therapy in Tuberous Sclerosis Complex (TSC; caused by variants in <jats:italic>TSC1<\/jats:italic> or <jats:italic>2<\/jats:italic>). We aim to summarize the mTOR pathway, the impact rapamycin has on the mTOR pathway, and the state of rapamycin use in the field of aging and longevity. Importantly, we will discuss the gaps in knowledge, pitfalls, and potential for the use of rapamycin to prevent aging\/age-related disease and discuss the lessons learned from achieving FDA approval of evirolimus for TSC-related seizures after many years of off-label use.<\/jats:p>","DOI":"10.3389\/fragi.2025.1628187","type":"journal-article","created":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T05:23:23Z","timestamp":1750397003000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":38,"title":["Rapamycin for longevity: the pros, the cons, and future perspectives"],"prefix":"10.3389","volume":"6","author":[{"given":"Kelley M.","family":"Roark","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"Philip H.","family":"Iffland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.molcel.2018.08.002","article-title":"Self-digestion for lifespan extension: enhanced autophagy delays aging","volume":"71","author":"Arensman","year":"2018","journal-title":"Mol. Cell"},{"key":"B2","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1093\/gerona\/glw064","article-title":"Intermittent administration of rapamycin extends the life span of female C57BL\/6J mice","volume":"71","author":"Arriola Apelo","year":"2016","journal-title":"Journals Gerontology Ser. A Biol. Sci. Med. Sci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e16351","DOI":"10.7554\/eLife.16351","article-title":"Transient rapamycin treatment can increase lifespan and healthspan in middle-aged mice","volume":"5","author":"Bitto","year":"2016","journal-title":"eLife"},{"key":"B4","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.yebeh.2018.09.020","article-title":"The use of rapamycin in patients with tuberous sclerosis complex: long-term results","volume":"88","author":"Canpolat","year":"2018","journal-title":"Epilepsy & Behav."},{"key":"B5","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s11357-019-00113-y","article-title":"Topical rapamycin reduces markers of senescence and aging in human skin: an exploratory, prospective, randomized trial","volume":"41","author":"Chung","year":"2019","journal-title":"GeroScience"},{"key":"B6","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1126\/science.1173635","article-title":"Caloric restriction delays disease onset and mortality in rhesus monkeys","volume":"325","author":"Colman","year":"2009","journal-title":"Sci. (New York, N.Y.)"},{"key":"B7","doi-asserted-by":"publisher","first-page":"a022442","DOI":"10.1101\/cshperspect.a022442","article-title":"mTOR signaling in epilepsy: insights from malformations of cortical development","volume":"5","author":"Crino","year":"2015","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/nrneurol.2016.81","article-title":"The mTOR signalling cascade: paving new roads to cure neurological disease","volume":"12","author":"Crino","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"24","DOI":"10.20517\/jca.2023.10","article-title":"The mTOR signaling pathway in cardiac aging","volume":"3","author":"Dai","year":"2023","journal-title":"J. Cardiovasc. Aging"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1111\/j.1600-6143.2007.01929.x","article-title":"Sirolimus\u2010associated infertility: case report and literature review of possible mechanisms","volume":"7","author":"Deutsch","year":"2007","journal-title":"Am. J. Transplant."},{"key":"B11","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.pediatrneurol.2019.11.017","article-title":"Cannabidiol elevates mechanistic target of rapamycin inhibitor levels in patients with tuberous sclerosis complex","volume":"105","author":"Ebrahimi-Fakhari","year":"2020","journal-title":"Pediatr. Neurol."},{"key":"B13","unstructured":"Handbook of the biology of aging\n          \n          \n          2005"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1016\/S0140-6736(16)31419-2","article-title":"Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study","volume":"388","author":"French","year":"2016","journal-title":"Lancet"},{"key":"B15","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41392-022-01251-0","article-title":"Aging and aging-related diseases: from molecular mechanisms to interventions and treatments","volume":"7","author":"Guo","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"B16","doi-asserted-by":"publisher","first-page":"88","DOI":"10.4103\/0976-500X.130046","article-title":"Off-label use of medicine: perspective of physicians, patients, pharmaceutical companies and regulatory authorities","volume":"5","author":"Gupta","year":"2014","journal-title":"J. Pharmacol. & Pharmacother."},{"key":"B17","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nature08221","article-title":"Rapamycin fed late in life extends lifespan in genetically heterogeneous mice","volume":"460","author":"Harrison","year":"2009","journal-title":"Nature"},{"key":"B18","unstructured":"Rapamycin prescription online: doctor-Prescribed for anti-aging (no date) healthspan\n          \n          \n          2025"},{"key":"B19","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1126\/science.1715094","article-title":"Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast","volume":"253","author":"Heitman","year":"1991","journal-title":"Science"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.2337\/db09-1324","article-title":"Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluconeogenesis and impairing lipid deposition in adipose tissue","volume":"59","author":"Houde","year":"2010","journal-title":"Diabetes"},{"key":"B21","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1007\/s11357-024-01221-0","article-title":"Evaluation of off-label rapamycin use on oral health","volume":"46","author":"Hudson","year":"2024","journal-title":"GeroScience"},{"key":"B22","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1146\/annurev-pathol-052016-100138","article-title":"Focal cortical dysplasia: gene mutations, cell signaling, and therapeutic implications","volume":"12","author":"Iffland","year":"2017","journal-title":"Annu. Rev. Pathology"},{"key":"B23","doi-asserted-by":"publisher","first-page":"3872","DOI":"10.1093\/brain\/awac044","article-title":"NPRL3 loss alters neuronal morphology, mTOR localization, cortical lamination and seizure threshold","volume":"145","author":"Iffland","year":"2022","journal-title":"Brain"},{"key":"B24","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/nature11861","article-title":"mTOR is a key modulator of ageing and age-related disease","volume":"493","author":"Johnson","year":"2013","journal-title":"Nature"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1007\/s11357-023-00818-1","article-title":"Evaluation of off-label rapamycin use to promote healthspan in 333 adults","volume":"45","author":"Kaeberlein","year":"2023","journal-title":"GeroScience"},{"key":"B26","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.cmet.2016.05.009","article-title":"The mechanistic Target of Rapamycin: the grand conducTOR of metabolism and aging","volume":"23","author":"Kennedy","year":"2016","journal-title":"Cell metab."},{"key":"B27","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/ncb2152","article-title":"AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1","volume":"13","author":"Kim","year":"2011","journal-title":"Nat. cell Biol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.cell.2005.01.027","article-title":"Understanding the odd science of aging","volume":"120","author":"Kirkwood","year":"2005","journal-title":"Cell"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1007\/s11357-023-00935-x","article-title":"Blazing a trail for the clinical use of rapamycin as a geroprotecTOR","volume":"45","author":"Konopka","year":"2023","journal-title":"GeroScience"},{"key":"B30","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.exger.2017.12.026","article-title":"A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: immunological, physical performance, and cognitive effects","volume":"105","author":"Kraig","year":"2018","journal-title":"Exp. Gerontol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1002\/ana.23960","article-title":"Everolimus treatment of refractory epilepsy in tuberous sclerosis complex","volume":"74","author":"Krueger","year":"2013","journal-title":"Ann. Neurology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1126\/science.1215135","article-title":"Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity","volume":"335","author":"Lamming","year":"2012","journal-title":"Sci. (New York, N.y.)"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e152","DOI":"10.1016\/S2666-7568(23)00258-1","article-title":"Targeting ageing with rapamycin and its derivatives in humans: a systematic review","volume":"5","author":"Lee","year":"2024","journal-title":"Lancet Healthy Longev."},{"key":"B34","doi-asserted-by":"publisher","first-page":"eabe7365","DOI":"10.1126\/science.abe7365","article-title":"Antiaging diets: separating fact from fiction","volume":"374","author":"Lee","year":"2021","journal-title":"Science"},{"key":"B35","doi-asserted-by":"publisher","first-page":"4766","DOI":"10.1093\/brain\/awad231","article-title":"Models of KPTN-related disorder implicate mTOR signalling in cognitive and overgrowth phenotypes","volume":"146","author":"Levitin","year":"2023","journal-title":"Brain"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e3000288","DOI":"10.1371\/journal.pbio.3000288","article-title":"ULK1-ATG13 and their mitotic phospho-regulation by CDK1 connect autophagy to cell cycle","volume":"18","author":"Li","year":"2020","journal-title":"PLOS Biol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/acel.12338","article-title":"Interventions to slow aging in humans: are we ready?","volume":"14","author":"Longo","year":"2015","journal-title":"Aging Cell"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","article-title":"The hallmarks of aging","volume":"153","author":"L\u00f3pez-Ot\u00edn","year":"2013","journal-title":"Cell"},{"key":"B39","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.cmet.2019.01.018","article-title":"Caloric restriction mimetics against age-associated disease: targets, mechanisms, and therapeutic potential","volume":"29","author":"Madeo","year":"2019","journal-title":"Cell Metab."},{"key":"B40","doi-asserted-by":"publisher","first-page":"268ra179","DOI":"10.1126\/scitranslmed.3009892","article-title":"mTOR inhibition improves immune function in the elderly","volume":"6","author":"Mannick","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/s43587-023-00416-y","article-title":"Targeting the biology of aging with mTOR inhibitors","volume":"3","author":"Mannick","year":"2023","journal-title":"Nat. aging"},{"key":"B42","doi-asserted-by":"publisher","first-page":"eaaq1564","DOI":"10.1126\/scitranslmed.aaq1564","article-title":"TORC1 inhibition enhances immune function and reduces infections in the elderly","volume":"10","author":"Mannick","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.devcel.2020.01.025","article-title":"Autophagic degradation of NBR1 restricts metastatic outgrowth during mammary tumor progression","volume":"52","author":"Marsh","year":"2020","journal-title":"Dev. Cell"},{"key":"B44","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/nature11432","article-title":"Impact of caloric restriction on health and survival in rhesus monkeys: the NIA study","volume":"489","author":"Mattison","year":"2012","journal-title":"Nature"},{"key":"B45","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1093\/jn\/10.1.63","article-title":"The effect of retarded growth upon the length of life span and upon the ultimate body size: one figure","volume":"10","author":"McCay","year":"1935","journal-title":"J. Nutr."},{"key":"B46","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12979-020-00181-1","article-title":"The immune response to influenza in older humans: beyond immune senescence","volume":"17","author":"McElhaney","year":"2020","journal-title":"Immun. & Ageing"},{"key":"B47","doi-asserted-by":"publisher","first-page":"5422","DOI":"10.1523\/JNEUROSCI.0955-08.2008","article-title":"Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function","volume":"28","author":"Meikle","year":"2008","journal-title":"J. Neurosci."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/j.cmet.2023.06.008","article-title":"When a calorie is not just a calorie: diet quality and timing as mediators of metabolism and healthy aging","volume":"35","author":"Mihaylova","year":"2023","journal-title":"Cell metab."},{"key":"B49","doi-asserted-by":"publisher","first-page":"908","DOI":"10.18632\/aging.206235","article-title":"Influence of rapamycin on safety and healthspan metrics after one year: PEARL trial results","volume":"17","author":"Moel","year":"2025","journal-title":"Aging (Albany NY)"},{"key":"B50","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.1111\/ene.15975","article-title":"Everolimus precision therapy for the GATOR1-related epilepsies: a case series","volume":"30","author":"Moloney","year":"2023","journal-title":"Eur. J. Neurology"},{"key":"B51","doi-asserted-by":"publisher","first-page":"F1000 Faculty Rev-998","DOI":"10.12688\/f1000research.17196.1","article-title":"mTOR as a central regulator of lifespan and aging","volume":"8","author":"Papadopoli","year":"2019","journal-title":"F1000Research"},{"key":"B52","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1038\/s41467-023-38401-z","article-title":"Redefining the role of AMPK in autophagy and the energy stress response","volume":"14","author":"Park","year":"2023","journal-title":"Nat. Commun."},{"key":"B53","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1080\/15548627.2019.1598751","article-title":"Dual roles of ULK1 (unc-51 like autophagy activating kinase 1) in cytoprotection against lipotoxicity","volume":"16","author":"Park","year":"2019","journal-title":"Autophagy"},{"key":"B54","doi-asserted-by":"publisher","first-page":"182ra53","DOI":"10.1126\/scitranslmed.3005271","article-title":"Rapamycin prevents seizures after depletion of STRADA in a rare neurodevelopmental disorder","volume":"5","author":"Parker","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1002\/cam4.761","article-title":"Oral mucosal injury caused by mammalian target of rapamycin inhibitors: emerging perspectives on pathobiology and impact on clinical practice","volume":"5","author":"Peterson","year":"2016","journal-title":"Cancer Med."},{"key":"B56","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1093\/gerona\/glz157","article-title":"Differential effects of rapamycin on glucose metabolism in nine inbred strains","volume":"75","author":"Reifsnyder","year":"2020","journal-title":"Journals Gerontology Ser. A Biol. Sci. Med. Sci."},{"key":"B57","doi-asserted-by":"publisher","first-page":"6894","DOI":"10.1038\/s41467-022-34487-z","article-title":"Distinct immunological and molecular signatures underpinning influenza vaccine responsiveness in the elderly","volume":"13","author":"Riese","year":"2022","journal-title":"Nat. Commun."},{"key":"B58","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.cell.2011.07.030","article-title":"Autophagy and aging","volume":"146","author":"Rubinsztein","year":"2011","journal-title":"Cell"},{"key":"B59","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/nrc1974","article-title":"mTOR and cancer: insights into a complex relationship","volume":"6","author":"Sabatini","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"B60","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/0092-8674(94)90570-3","article-title":"RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs","volume":"78","author":"Sabatini","year":"1994","journal-title":"Cell"},{"key":"B61","doi-asserted-by":"publisher","first-page":"704978","DOI":"10.3389\/fneur.2022.704978","article-title":"Antiepileptic effect and safety profile of rapamycin in pediatric patients with tuberous sclerosis complex","volume":"13","author":"Sadowski","year":"2022","journal-title":"Front. Neurology"},{"key":"B62","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","article-title":"mTOR signaling in growth, metabolism, and disease","volume":"168","author":"Saxton","year":"2017","journal-title":"Cell"},{"key":"B63","doi-asserted-by":"publisher","first-page":"7824","DOI":"10.1038\/s41598-019-44106-5","article-title":"Rapamycin modulates tissue aging and lifespan independently of the gut microbiota in Drosophila","volume":"9","author":"Schinaman","year":"2019","journal-title":"Sci. Rep."},{"key":"B64","doi-asserted-by":"publisher","first-page":"e9979","DOI":"10.1371\/journal.pone.0009979","article-title":"Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-\u03b2 levels in a mouse model of alzheimer\u2019s disease","volume":"5","author":"Spilman","year":"2010","journal-title":"PLoS ONE"},{"key":"B65","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.arr.2011.12.006","article-title":"Dietary restriction in rats and mice: a meta-analysis and review of the evidence for genotype-dependent effects on lifespan","volume":"11","author":"Swindell","year":"2012","journal-title":"Ageing Res. Rev."},{"key":"B66","doi-asserted-by":"publisher","first-page":"e01091","DOI":"10.1002\/prp2.1091","article-title":"Rapamycin treatment increases survival, autophagy biomarkers and expression of the anti\u2010aging klotho protein in elderly mice","volume":"11","author":"Sz\u0151ke","year":"2023","journal-title":"Pharmacol. Res. & Perspect."},{"key":"B67","doi-asserted-by":"publisher","first-page":"e13753","DOI":"10.1111\/acel.13753","article-title":"Role of autophagy in aging: the good, the bad, and the ugly","volume":"22","author":"Tabibzadeh","year":"2023","journal-title":"Aging Cell"},{"key":"B68","volume-title":"Has Bryan Johnson\u2019s anti-aging experiment backfired? Biohacker spending $2 million-a-year admits to a costly misstep","year":"2025"},{"key":"B69","article-title":"FDA\u2019s concerns with unapproved GLP-1 drugs used for weight loss","year":"2025"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/nature07216","article-title":"Puzzles, promises and a cure for ageing","volume":"454","author":"Vijg","year":"2008","journal-title":"Nature"},{"key":"B71","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/j.1474-9726.2012.00832.x","article-title":"Rapamycin slows aging in mice","volume":"11","author":"Wilkinson","year":"2012","journal-title":"Aging cell"},{"key":"B72","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1002\/cpdd.1262","article-title":"Pharmacokinetic drug-drug interaction with coadministration of cannabidiol and everolimus in a phase 1 healthy volunteer trial","volume":"12","author":"Wray","year":"2023","journal-title":"Clin. Pharmacol. Drug Dev."},{"key":"B73","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1002\/ana.21331","article-title":"Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex","volume":"63","author":"Zeng","year":"2008","journal-title":"Ann. neurology"},{"key":"B74","doi-asserted-by":"publisher","first-page":"656201","DOI":"10.3389\/fcell.2021.656201","article-title":"Targeting the mitochondria-proteostasis Axis to delay aging","volume":"9","author":"Zimmermann","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"dmm049345","DOI":"10.1242\/dmm.049345","article-title":"Autophagy takes it all \u2013 autophagy inducers target immune aging","volume":"15","author":"Zinecker","year":"2022","journal-title":"Dis. Models & Mech."}],"container-title":["Frontiers in Aging"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fragi.2025.1628187\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T05:23:24Z","timestamp":1750397004000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fragi.2025.1628187\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,20]]},"references-count":74,"alternative-id":["10.3389\/fragi.2025.1628187"],"URL":"https:\/\/doi.org\/10.3389\/fragi.2025.1628187","relation":{},"ISSN":["2673-6217"],"issn-type":[{"value":"2673-6217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,20]]},"article-number":"1628187"}}